LCEYX
Price
$18.31
Change
-$0.01 (-0.05%)
Updated
Jun 5 closing price
Net Assets
10.22B
RMEBX
Price
$57.64
Change
-$0.04 (-0.07%)
Updated
Jun 5 closing price
Net Assets
105.22B
Interact to see
Advertisement

LCEYX vs RMEBX

Header iconLCEYX vs RMEBX Comparison
Open Charts LCEYX vs RMEBXBanner chart's image
Invesco Diversified Dividend Y
Price$18.31
Change-$0.01 (-0.05%)
VolumeN/A
Net Assets10.22B
American Funds American Mutual R2E
Price$57.64
Change-$0.04 (-0.07%)
VolumeN/A
Net Assets105.22B
LCEYX vs RMEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LCEYX vs. RMEBX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LCEYX is a Buy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 105B vs. LCEYX (10.2B). LCEYX pays higher dividends than RMEBX: LCEYX (1.64) vs RMEBX (1.16). LCEYX was incepted earlier than RMEBX: LCEYX (17 years) vs RMEBX (11 years). RMEBX (1.07) is less costly to investors than LCEYX (0.57). LCEYX is a more actively managed with annual turnover of: 47.00 vs. RMEBX (31.00). RMEBX has a lower initial minimum investment than LCEYX: RMEBX (250) vs LCEYX (1000). RMEBX annual gain was more profitable for investors over the last year : 8.30 vs. LCEYX (-0.49). RMEBX return over 5 years is better than : 49.85 vs. LCEYX (7.06).
LCEYXRMEBXLCEYX / RMEBX
Total Expense Ratio0.571.0753%
Annual Report Gross Expense Ratio0.571.0753%
Fund Existence17 years11 years-
Gain YTD2.9975.34956%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets10.2B105B10%
Annual Yield % from dividends1.641.16142%
Returns for 1 year-0.498.30-6%
Returns for 3 years-1.3517.96-7%
Returns for 5 years7.0649.8514%
Returns for 10 years15.0868.2122%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERV5.720.43
+8.22%
Verve Therapeutics
VRNT18.780.97
+5.45%
Verint Systems
CHRS0.80N/A
+0.48%
Coherus Oncology Inc
CHSCN25.15-0.05
-0.20%
CHS
PRI265.13-2.99
-1.12%
PRIMERICA